Platinum nanoparticles induce damage to DNA and inhibit DNA replication

Area of Science:

• Nanomedicine
• Biochemistry
• Materials Science

Background:

• Platinum nanoparticles (PtNPs) are sparsely tested but may rival complex platinum compounds.
• Understanding PtNPs' biological effects is crucial for their therapeutic potential.

Purpose of the Study:

• To investigate the in vitro effects of PtNPs on DNA replication, bacterial cultures, human cells, and erythrocytes.
• To compare PtNPs with cisplatin (CisPt), a traditional chemotherapy agent.

Main Methods:

• Characterization of PtNPs using dynamic light scattering, zeta potential, X-ray fluorescence, UV/vis, and atomic absorption spectrometry.
• Assessing DNA damage via polymerase chain reaction, DNA sequencing, and denaturation experiments.
• Evaluating antibacterial, cytostatic, and cytotoxic effects using growth curves; oxidative stress measured by GSH/GSSG ratio.

Main Results:

• PtNPs inhibited DNA replication and altered DNA structure at higher concentrations.
• Liposome-encapsulated PtNPs (LipoPtNPs) induced 2.4x more DNA damage than CisPt and bare PtNPs.
• LipoPtNPs demonstrated enhanced antibacterial, cytostatic, and cytotoxic effects.
• Both bare and encapsulated PtNPs caused less oxidative stress in erythrocytes compared to CisPt.

Conclusions:

• PtNPs exhibit significant DNA damaging and cytotoxic properties.
• Liposome encapsulation potentiates the therapeutic effects of PtNPs.
• PtNPs present a potentially safer alternative to cisplatin regarding erythrocyte oxidative stress.